IL6 and hepatocellular carcinoma: In the present study, Rh4 led to the inactivation of IL-6/STAT3 signaling in LPS-stimulated HCC cells and in the tissues of mouse HCC subcutaneous transplanted tumor, evidenced by reduced IL-6 and p-STAT3 expression.